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No gold standard method currently exists for the devel-
opment of a core outcome set (COS) although key
issues to consider have been identified [1]. Methodologi-
cal decisions in the design of a project to develop a COS
for otitis media with effusion (OME) in children with
cleft palate (CP) will be explained.
Stakeholder groups
Clinicians involved in the management of OME were
identified as: ENT surgeons; audiologists; cleft surgeons;
speech and language therapists; specialist nurses. Discus-
sions with CLAPA patient groups resulted in a Delphi
for patients (7-11, 12-16 years), their parents and adults
with CP and OME.
Separate Delphi panels
A Delphi exercise has been undertaken with each clini-
cal stakeholder group separately. This method does not
assume that different stakeholder groups will have the
same outcome priorities.
Describing outcomes for patients and their
parents
A lay description written for each outcome was
reviewed by CLAPA groups and reading age assessed.
Understanding was tested in a subsample using the
think aloud method.
Delivery of the Delphi online
Each round of the Delphi was delivered online using a
bespoke system that managed participation invitations ,
reminders, data collection and reporting.
Integration of clinical and patient views
Results of the separate Delphi surveys for each stake-
holder group will be shared with all participants with an
opportunity to re-score. Clinicians, adults, patients and
their parents who have taken part in a Delphi panel/
qualitative interview will be invited to a consensus meet-
ing, facilitated by a Study Advisory Group and CLAPA
members, to discuss the final COS.
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